Arcturus Therapeutics Holdings Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Arcturus Therapeutics Holdings Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2018 to 2023.
  • Arcturus Therapeutics Holdings Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $2.19M.
  • Arcturus Therapeutics Holdings Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$24.1M, a 742% decline from 2022.
  • Arcturus Therapeutics Holdings Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$2.86M, a 106% decline from 2021.
  • Arcturus Therapeutics Holdings Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $48M, a 89% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$24.1M -$21.2M -742% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 -$2.86M -$50.9M -106% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $48M -$388M -89% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 $436M +$394M +941% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 $41.9M +$31.7M +311% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $10.2M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.